HKG:1177 Sino Biopharm

1 min read

HKG:1177 Sino Biopharm operates in the field of Medicine. The Group’s business works in a fully integrated chain which spans from R&D to manufacture and sales of pharmaceutical products, covering a vast array of biopharmaceutical, chemical and modernized Chinese medicines. Interim result 2022 are favorable for dividends (+200%) yet EPS fell 77%

HKG:1177 Sino Biopharm

Last update: 3-Aug-24

Quick overview:

    • Yield: 1.79%

(See here Top 10 highest yield)

    • Lot: 1000
    • Price/Earnings ratio : 23.33 (Ideal <20 )
    • Earnings per share : 0.120 (Ideal >0.001)
    • Price as per 3-Aug-24 : HK$2.80
    • Ex-Dividend Date coming up:  N/A

See here all upcoming Ex-Dividend dates

2024 Interim results: 0

Log in, to see this page

Get access to expert data in 5 minutes

Sign up for free

and get immediate access to

  • The Top 25 highest yield dividend growth companies. (updated weekly)

  • All Hong Kong Blue Chip stocks (updated monthly)

  • Stock of the week, in your mail box (only 2 mail per week)

YES, FOR FREE

We promise to only send you amazing helpful emails!
```

Selected or you: